EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $466,828 | +47.4% | 16,455 | +51.9% | 0.01% | +16.7% |
| Q4 2022 | $316,619 | -25.3% | 10,832 | +26.3% | 0.01% | -45.5% |
| Q1 2022 | $424,000 | +10.1% | 8,576 | +33.5% | 0.01% | -56.0% |
| Q4 2019 | $385,000 | -35.5% | 6,424 | -39.2% | 0.02% | -28.6% |
| Q3 2019 | $597,000 | +80.4% | 10,560 | +77.7% | 0.04% | -5.4% |
| Q2 2019 | $331,000 | -6.2% | 5,944 | -15.1% | 0.04% | -36.2% |
| Q1 2019 | $353,000 | – | 7,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |